Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Dutasteride is a safe and effective treatment for hair loss.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Transplanting one's own hair follicle cells can improve hair loss in men and women, and is particularly effective in women.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Topical finasteride is an effective and safer treatment for male hair loss.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

DHEA treatment helps grow pubic hair and boosts mood in girls with adrenal issues.

Low-dose dutasteride effectively and safely promotes hair growth in men.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.